CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Fast return on investments and greater profit margins
4.1.2. Growing interest of market players in discovering various types of polymers
4.1.3. Faster testing and improved portability through microfluidic chip miniaturisation
4.2. Market Restraints & Challenges
4.2.1. Complex and time-consuming regulatory approval process
4.2.2. Standardization/ commercialisation of microfluidic devices
4.2.3. Incorporation of microfluidics technology into existing workflows
4.3. Market Opportunities
4.3.1. Expanding applications of drug delivery techniques
4.3.2. Increasing applications in microfluidic technology
CHAPTER 5. GLOBAL MICROFLUIDICS MARKET – BY COMPONENT
5.1. By Type
5.1.1. Microfluidic Sensors
5.1.2. Microfluidic Chips
5.1.3. Microneedles
5.1.4. Micropumps
5.1.5. Others
5.2. Microfluidic Components Market, By Material
5.2.1. Silicon
5.2.2. Glass
5.2.3. Polymer
5.2.4. Others
CHAPTER 6. GLOBAL MICROFLUIDICS MARKET – BY APPLICATION
6.1. Pharmaceutical and Life Science Research
6.1.1. Lab Analytics
6.1.1.1. Genomic Analysis
6.1.1.2. Proteomic Analysis
6.1.1.3. Capillary Electrophoresis
6.1.1.4. Cell-Based Assays
6.1.2. Microreaction
6.1.3. Microdispensing
6.2. In Vitro Diagnostics
6.2.1. Clinical Diagnostics
6.2.2. Point-Of-Care Testing
6.3. Drug Delivery
6.4. Laboratory Testing
6.4.1. Environmental Testing
6.4.2. Industrial Testing
6.4.3. Agro Food Testing
CHAPTER 7. GLOBAL MICROFLUIDICS MARKET - BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.2.4. Costa Rica
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Chile
7.3.4. Columbia
7.3.5. Others
7.4. Europe
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Netherlands
7.4.8. Switzerland
7.4.9. Poland
7.4.10. Others
7.5. APAC
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. South Korea
7.5.5. Australia & New Zealand
7.5.6. Malaysia
7.5.7. Singapore
7.5.8. Others
7.6. Middle East & Africa
7.6.1. UAE
7.6.2. Saudi Arabia
7.6.3. Iran
7.6.4. Iraq
7.6.5. Qatar
7.6.6. South Africa
7.6.7. Algeria
7.6.8. Morocco
7.6.9. Nigeria
7.6.10. Egypt
7.6.8. Others
CHAPTER 8. GLOBAL MICROFLUIDICS MARKET - COMPANY PROFILES
8.1. F. Hoffmann-La Roche
8.2. Agilent Technologies
8.3. Becton, Dickinson and Company
8.4. Thermo Fisher Scientific
8.5. Bio-Rad Laboratories
8.6. Perkinelmer, Inc.
8.7. Illumina, Inc.
8.8. Danaher Corporation
8.9. Fluidigm Corporation
8.10. Microfluidic Chipshop
8.11.Qiagen GmbH
8.12. Abbott Laboratories
8.13. Biomérieux, Inc.
8.14. Dolomite Microfluidics
8.15. Micronit Microtechnologies
8.16. Cellix Ltd
8.17. Elveflow Microfluidics
CHAPTER 9. GLOBAL MICROFLUIDICS MARKET - COMPETITIVE LANDSCAPE
9.1. Market Share Analysis
9.2. Strategies adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 10. MARKET INSIGHTS
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
CHAPTER 11. APPENDIX
11.1. List of Tables
11.2. List of Figures
